Comments
Loading...
Ultragenyx Pharmaceutical Rapporto sugli interessi allo scoperto
RARENASDAQ
Report sulle vendite allo scoperto
Il short interest su Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 8.32M a 7.95M. Questo rappresenta il 8.54% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Ultragenyx Pharmaceutical Corp (XNAS:RARE) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 1.54M azioni scambiate al giorno, ci vorrebbero 5.15 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
7.95M
Vendite allo scoperto %
8.54%
Giorni di copertura
5.15
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc. | 09/15/2025 | 09/24/2025 | 8.54% | 93,071,315 | 7,947,955 | 1,543,762 | 5.15 | |
RARE | Ultragenyx Pharmaceutical Inc. | 08/29/2025 | 09/10/2025 | 8.94% | 93,071,315 | 8,320,958 | 1,227,310 | 6.78 | |
RARE | Ultragenyx Pharmaceutical Inc. | 08/15/2025 | 08/26/2025 | 9.03% | 93,071,315 | 8,405,280 | 1,733,208 | 4.85 | |
RARE | Ultragenyx Pharmaceutical Inc. | 07/31/2025 | 08/11/2025 | 8.21% | 93,071,315 | 7,638,230 | 2,569,963 | 2.97 | |
RARE | Ultragenyx Pharmaceutical Inc. | 07/15/2025 | 07/24/2025 | 9.65% | 91,241,707 | 8,801,643 | 3,531,858 | 2.49 | |
RARE | Ultragenyx Pharmaceutical Inc. | 06/30/2025 | 07/10/2025 | 7.47% | 91,241,707 | 6,820,252 | 1,007,073 | 6.77 | |
RARE | Ultragenyx Pharmaceutical Inc. | 06/13/2025 | 06/25/2025 | 6.66% | 91,241,707 | 6,081,072 | 1,188,261 | 5.12 | |
RARE | Ultragenyx Pharmaceutical Inc. | 05/30/2025 | 06/10/2025 | 6.08% | 91,241,707 | 5,546,745 | 1,002,669 | 5.53 | |
RARE | Ultragenyx Pharmaceutical Inc. | 05/15/2025 | 05/27/2025 | 6.46% | 91,241,707 | 5,891,832 | 1,033,789 | 5.7 | |
RARE | Ultragenyx Pharmaceutical Inc. | 04/30/2025 | 05/09/2025 | 6.07% | 91,241,707 | 5,535,742 | 884,836 | 6.26 | |
RARE | Ultragenyx Pharmaceutical Inc. | 04/15/2025 | 04/25/2025 | 6.02% | 90,599,339 | 5,456,189 | 1,127,794 | 4.84 | |
RARE | Ultragenyx Pharmaceutical Inc. | 03/31/2025 | 04/09/2025 | 4.99% | 90,599,339 | 4,525,008 | 685,503 | 6.6 | |
RARE | Ultragenyx Pharmaceutical Inc. | 03/14/2025 | 03/25/2025 | 5.97% | 80,660,200 | 4,813,611 | 794,527 | 6.06 | |
RARE | Ultragenyx Pharmaceutical Inc. | 02/28/2025 | 03/11/2025 | 5.69% | 80,660,200 | 4,587,206 | 718,412 | 6.39 | |
RARE | Ultragenyx Pharmaceutical Inc. | 02/14/2025 | 02/26/2025 | 5.31% | 80,660,200 | 4,284,000 | 692,339 | 6.19 | |
RARE | Ultragenyx Pharmaceutical Inc. | 01/31/2025 | 02/11/2025 | 5.17% | 80,503,342 | 4,164,361 | 752,136 | 5.54 | |
RARE | Ultragenyx Pharmaceutical Inc. | 01/15/2025 | 01/27/2025 | 5.28% | 80,503,342 | 4,250,759 | 1,288,898 | 3.3 | |
RARE | Ultragenyx Pharmaceutical Inc. | 12/31/2024 | 01/10/2025 | 4.99% | 80,503,342 | 4,015,892 | 873,761 | 4.6 | |
RARE | Ultragenyx Pharmaceutical Inc. | 12/13/2024 | 12/24/2024 | 4.61% | 80,503,342 | 3,713,992 | 648,542 | 5.73 | |
RARE | Ultragenyx Pharmaceutical Inc. | 11/29/2024 | 12/10/2024 | 4.20% | 80,503,342 | 3,379,045 | 579,980 | 5.83 | |
RARE | Ultragenyx Pharmaceutical Inc. | 11/15/2024 | 11/26/2024 | 4.16% | 80,503,342 | 3,346,228 | 1,139,872 | 2.94 | |
RARE | Ultragenyx Pharmaceutical Inc. | 10/31/2024 | 11/11/2024 | 3.95% | 80,503,342 | 3,179,627 | 556,554 | 5.71 | |
RARE | Ultragenyx Pharmaceutical Inc. | 10/15/2024 | 10/24/2024 | 3.94% | 80,324,264 | 3,164,918 | 688,310 | 4.6 | |
RARE | Ultragenyx Pharmaceutical Inc. | 09/30/2024 | 10/09/2024 | 3.59% | 80,324,264 | 2,887,535 | 602,342 | 4.79 | |
RARE | Ultragenyx Pharmaceutical Inc. | 09/13/2024 | 09/24/2024 | 4.50% | 80,324,264 | 3,614,532 | 576,977 | 6.26 | |
RARE | Ultragenyx Pharmaceutical Inc. | 08/30/2024 | 09/11/2024 | 4.37% | 80,324,264 | 3,509,261 | 681,631 | 5.15 | |
RARE | Ultragenyx Pharmaceutical Inc. | 07/31/2024 | 08/09/2024 | 5.26% | 80,324,264 | 4,226,979 | 644,620 | 6.56 | |
RARE | Ultragenyx Pharmaceutical Inc. | 07/15/2024 | 07/24/2024 | 5.54% | 78,728,313 | 4,362,643 | 760,049 | 5.74 | |
RARE | Ultragenyx Pharmaceutical Inc. | 06/28/2024 | 07/10/2024 | 5.38% | 78,728,313 | 4,235,727 | 1,202,594 | 3.52 | |
RARE | Ultragenyx Pharmaceutical Inc. | 06/14/2024 | 06/26/2024 | 6.40% | 78,728,313 | 5,041,498 | 1,110,094 | 4.54 | |
RARE | Ultragenyx Pharmaceutical Inc. | 05/31/2024 | 06/11/2024 | 6.26% | 71,292,415 | 4,465,450 | 736,533 | 6.06 | |
RARE | Ultragenyx Pharmaceutical Inc. | 05/15/2024 | 05/24/2024 | 6.08% | 71,292,415 | 4,337,729 | 786,393 | 5.52 | |
RARE | Ultragenyx Pharmaceutical Inc. | 04/30/2024 | 05/09/2024 | 6.52% | 71,292,415 | 4,650,347 | 682,037 | 6.82 | |
RARE | Ultragenyx Pharmaceutical Inc. | 04/15/2024 | 04/24/2024 | 6.15% | 71,292,415 | 4,382,486 | 739,361 | 5.93 | |
RARE | Ultragenyx Pharmaceutical Inc. | 03/28/2024 | 04/09/2024 | 4.95% | 79,136,675 | 3,918,427 | 553,110 | 7.08 | |
RARE | Ultragenyx Pharmaceutical Inc. | 03/15/2024 | 03/26/2024 | 4.78% | 79,136,675 | 3,780,931 | 778,413 | 4.86 | |
RARE | Ultragenyx Pharmaceutical Inc. | 02/29/2024 | 03/11/2024 | 4.89% | 79,136,675 | 3,867,566 | 750,922 | 5.15 | |
RARE | Ultragenyx Pharmaceutical Inc. | 02/15/2024 | 02/27/2024 | 4.50% | 79,136,675 | 3,558,020 | 627,599 | 5.67 | |
RARE | Ultragenyx Pharmaceutical Inc. | 01/31/2024 | 02/09/2024 | 4.33% | 78,915,338 | 3,414,342 | 888,900 | 3.84 | |
RARE | Ultragenyx Pharmaceutical Inc. | 01/12/2024 | 01/24/2024 | 5.22% | 78,915,338 | 4,116,209 | 910,678 | 4.52 | |
RARE | Ultragenyx Pharmaceutical Inc. | 12/29/2023 | 01/10/2024 | 5.15% | 78,915,338 | 4,060,198 | 653,448 | 6.21 | |
RARE | Ultragenyx Pharmaceutical Inc. | 12/15/2023 | 12/27/2023 | 4.23% | 78,915,338 | 3,339,794 | 890,577 | 3.75 | |
RARE | Ultragenyx Pharmaceutical Inc. | 11/30/2023 | 12/11/2023 | 4.10% | 78,915,338 | 3,238,184 | 668,693 | 4.84 | |
RARE | Ultragenyx Pharmaceutical Inc. | 11/15/2023 | 11/27/2023 | 4.44% | 78,915,338 | 3,500,936 | 849,772 | 4.12 | |
RARE | Ultragenyx Pharmaceutical Inc. | 10/31/2023 | 11/09/2023 | 5.28% | 78,915,338 | 4,163,945 | 1,733,887 | 2.4 | |
RARE | Ultragenyx Pharmaceutical Inc. | 10/13/2023 | 10/24/2023 | 4.27% | 78,122,920 | 3,339,348 | 891,128 | 3.75 | |
RARE | Ultragenyx Pharmaceutical Inc. | 09/29/2023 | 10/10/2023 | 5.75% | 68,289,586 | 3,929,203 | 694,376 | 5.66 |
In cerca di azioni più vendute allo scoperto?